Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Burlingame, California
- Most recent report
- 10-Q, filed Nov 5, 2026
- Incorporated
- Delaware
- Filings on record
- 798 filings
- On EDGAR
- CIK 1672619
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer
Financials 8 of 27
News 8 of 61
Prospectuses and Registrations 8 of 30
- 424B5 Prospectus supplement for an offering Jun 12, 2026
- 424B5 Prospectus supplement for an offering Jun 11, 2026
- S-8 Registration statement for an employee plan Mar 3, 2026
- S-8 Registration statement for an employee plan Dec 16, 2025
- S-3ASR Automatic shelf registration Aug 13, 2025
- 424B5 Prospectus supplement for an offering Jun 16, 2025
- 424B5 Prospectus supplement for an offering Jun 13, 2025
- S-8 Registration statement for an employee plan Mar 13, 2025
Proxies 8 of 18
- DEFA14A Extra proxy material Apr 27, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2026
- PRE 14A Preliminary proxy statement Apr 15, 2026
- DEFA14A Extra proxy material Apr 28, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2025
- DEFA14A Extra proxy material Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- PRE 14A Preliminary proxy statement Apr 15, 2024
Ownership 8 of 617
- 4 Insider reported a trade Nov 3, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 27, 2026
- 4 Insider reported a trade Oct 21, 2026
- 4 Insider reported a trade Oct 21, 2026
- 144 Notice of a proposed sale of restricted stock Oct 19, 2026
- 4 Insider reported a trade Oct 16, 2026
- 3 Insider reported their initial holding Oct 16, 2026
- 4 Insider reported a trade Oct 5, 2026
Other 8 of 45
- ARS Annual report sent to shareholders Apr 27, 2026
- S-3MEF Jun 13, 2025
- ARS Annual report sent to shareholders Apr 28, 2025
- EFFECT Notice that a registration became effective Apr 30, 2024
- CORRESP Reply to SEC staff Apr 26, 2024
- ARS Annual report sent to shareholders Apr 26, 2024
- UPLOAD Comment letter from SEC staff Apr 24, 2024
- CORRESP Reply to SEC staff Apr 18, 2024
Everything here comes from Enliven Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.